The CDMO, with 3,200 employees at 20 locations in the U.S., Europe and India, has a global footprint to help customers navigate their R&D and manufacturing challenges.
The company says it is investing in areas across the value chain to ensure its customers continue to enjoy the benefits of a global network with local access.
Despite Trump’s efforts to bring manufacturing back to the U.S., the threat of tariffs is accelerating an ongoing move to regional redundancy and capacity distribution.
The White House on Wednesday said pharmaceuticals are exempted from the reciprocal tariffs. Jefferies analysts called the impact on biopharma “minimal” at least for now.
The Swiss-headquartered company has scaled up its operations to become a leading contract development and manufacturing organization focused on profitable growth.
With capabilities supporting its next-generation ADC pipeline scaled up externally, Sutro Biopharma’s operations in San Carlos, California will cease this year.
The CDMO’s new packaging line will double annual vial output and support production of Verona Pharma’s chronic obstructive pulmonary disease drug Ohtuvayre.
Located in Carlsbad, California, the center will help customers to create end-to-end manufacturing workflows that can be scaled to support clinical and commercial activities.
The Myerstown expansion includes new packaging lines and automated logistics systems to streamline delivery of consumer health products such as Aleve and Claritin.
In the pharmaceutical industry, the pressure to produce high-quality products and remain competitive has never been greater. The rising costs of drug manufacturing and the increasing...
What’s next for pharma manufacturing in 2025? As the industry continues to respond to new scientific breakthroughs, supply chain pressures, and geopolitical tensions, the...
Pharmaceutical manufacturing operates in a high-stakes environment where regulatory compliance, product integrity, and operational uptime are non-negotiable. As the industry becomes...
